Literature DB >> 6896293

Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide.

L A Zwelling, D Kerrigan, S Michaels.   

Abstract

The effects upon cellular DNA and cytotoxicity produced by the anthracyclines 5-iminodaunorubicin and Adriamycin were studied in mouse leukemia L1210 cells. 5-Iminodaunorubicin produced protein-concealed DNA strand breaks as measured by alkaline elution as had other intercalators including Adriamycin. 5-Iminodaunorubicin produced DNA breaks more efficiently than did Adriamycin despite a lower potency for free radical formation. Many of the 5-iminodaunorubicin breaks measured in this assay may arise from apposed single-strand breaks (i.e., double-strand breaks). 5-Iminodaunorubicin produced breaks which disappeared within 1 to 2 hr following drug removal and were in this way similar to the breaks produced by the acridine intercalator 4'-(9-acridinylamino)methanesulfon-m-anisidide. Adriamycin produced more persistent breaks. Despite similarities in the kinetics of break disappearance, 5-iminodaunorubicin produced greater cytotoxicity than did 4'-(9-acridinylamino)methanesulfon-m-anisidide when compared at doses producing equal single-strand or double-strand breaks. Differences in the ratio of single-strand breaks to double-strand breaks and the associated cytotoxicity for 5-iminodaunorubicin and 4'-(9-acridinylamino)methanesulfon-m-anisidide indicate that a different mechanism is probably involved in the DNA break production by each agent. Differences between the cytotoxicity associated with the DNA break production by two agents with similar break disappearance kinetics indicate that intercalator-induced DNA breaks cannot be a uniformly lethal DNA lesion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6896293

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Depletion of topoisomerase II in isolated nuclei during a glucose-regulated stress response.

Authors:  J W Shen; J R Subjeck; R B Lock; W E Ross
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

2.  Telomere dysfunction alters the chemotherapeutic profile of transformed cells.

Authors:  K H Lee; K L Rudolph; Y J Ju; R A Greenberg; L Cannizzaro; L Chin; S R Weiler; R A DePinho
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

3.  Cellular and molecular pharmacology of 4'-epidoxorubicin in HeLa cells. Comparison with its parent drug, doxorubicin.

Authors:  O Cantoni; P Sestili; F Cattabeni; C Geroni; M Grandi; F C Giuliani
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

4.  Intracellular DNA damage produced by a series of diacridines.

Authors:  I A Roos; L P Wakelin; S J Henry
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

5.  Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis.

Authors:  J P Jaffrézou; T Levade; A Bettaïeb; N Andrieu; C Bezombes; N Maestre; S Vermeersch; A Rousse; G Laurent
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

6.  Survival of rat mammary tumor cell clones and DNA strand damage following adriamycin treatment.

Authors:  D P Evans; R E Meyn; S P Tomasovic
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

7.  Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.

Authors:  E M Nelson; K M Tewey; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

8.  Loss of viability and induction of DNA damage in human leukemic myeloblasts and lymphocytes by m-AMSA.

Authors:  L W Brox; A Belch; A Ng; E Pollock
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Protein-associated intercalator-induced DNA scission is enhanced by estrogen stimulation in human breast cancer cells.

Authors:  L A Zwelling; D Kerrigan; M E Lippman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

10.  Blocked 5'-termini in the fragments of chromosomal DNA produced in cells exposed to the antitumor drug 4'-[(9-acridinyl)-amino]methanesulphon-m-anisidide (mAMSA).

Authors:  B Marshall; R K Ralph; R Hancock
Journal:  Nucleic Acids Res       Date:  1983-06-25       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.